Neurospirituality in Clinical Neuroscience: Evidence, Gaps, and Implications

Neurospirituality: An Emerging Framework Linking Brain and Spirit

Neurospirituality is an interdisciplinary field that integrates neuroscience, neurology, palliative care, and the medical humanities to address the spiritual and existential dimensions of health. According to a 2026 narrative review (OpenAlex W7215068344), neurospirituality seeks to understand how meaning-making, connectedness, and existential well-being are reflected in brain function and clinical outcomes. The review distinguishes spirituality—defined as the search for meaning and connection beyond the self—from religiosity, which refers to organized beliefs and rituals. This conceptual clarity is particularly relevant for psychedelic research, where subjective experiences of meaning and transcendence are often central to therapeutic hypotheses.

Neural Correlates: Distributed Networks, Not Single Regions

Current evidence associates spiritual experiences with activity across distributed brain networks, rather than discrete regions. The review identifies the default mode network (DMN), salience network, and frontoparietal control network as key players in spiritual cognition. These networks are involved in self-referential thinking, emotional salience, and cognitive control, respectively. Importantly, the review emphasizes that these models are heuristic: spiritual experiences likely arise from domain-general cognitive processes rather than unique, spirituality-specific neural mechanisms. This insight challenges reductionist approaches and suggests that interventions targeting these networks—such as psychedelics that modulate DMN activity—may influence spiritual well-being indirectly, rather than by activating a dedicated 'spirituality circuit.'

Clinical Relevance: Correlational Evidence and Consensus-Based Care

Greater spiritual well-being is consistently associated with improved coping, resilience, and quality of life in palliative care and certain neurological disorders. The review notes that, in clinical practice, spirituality is often addressed through person-centered care and expert consensus rather than evidence-based protocols. While some studies suggest that spiritual interventions can support patients facing existential distress, the evidence base is limited by small samples, heterogeneous definitions, and cultural variability. Notably, the review finds a lack of robust, longitudinal trials that could establish causality or inform standardized clinical guidelines. This limitation is particularly salient for psychedelic-assisted therapies, where claims about meaning-making and existential benefit often outpace the available data.

• Concrete Example: In palliative care, spiritual well-being is linked to lower rates of depression and improved quality of life, yet interventions remain highly individualized and lack standardized outcome measures.

Policy and Research Implications: The Case for Rigorous, Interdisciplinary Study

The early-stage nature of neurospirituality presents both opportunities and challenges for clinical and regulatory frameworks. The review underscores the need for interdisciplinary, longitudinal, and culturally diverse research to clarify underlying mechanisms and strengthen clinical translation. For policymakers and regulators, this means that current clinical recommendations should be viewed as provisional, pending stronger evidence. For researchers designing psychedelic trials, the review highlights the importance of precise definitions, culturally sensitive measures, and the inclusion of spiritual well-being as a secondary outcome—rather than a primary endpoint—until more robust data are available. A non-obvious implication is that regulatory agencies may require more granular, mechanistic data before endorsing spirituality-based interventions, even as patient demand for meaning-centered care grows.

Risks, Limitations, and Unknowns in Neurospirituality Research

The evidence base for neurospirituality is constrained by several methodological and conceptual challenges. Most studies are correlational, making it difficult to disentangle causality from association. Definitions of spirituality vary widely across cultures and studies, complicating efforts to generalize findings or develop universal models. Sample sizes are often small, and longitudinal data are scarce. These limitations create a risk of overinterpreting preliminary findings or implementing interventions without adequate evidence of efficacy or safety. In the context of psychedelic research, there is a particular risk that enthusiasm for spiritual outcomes may outpace the science, leading to premature clinical adoption or regulatory approval. The review calls for caution and transparency in both clinical practice and public communication.

Looking Forward: Building a Robust Evidence Base for Neurospirituality

Neurospirituality offers a promising translational framework for integrating neuroscience with spiritual and existential dimensions of health, but the field remains in its infancy. Future research should prioritize large-scale, longitudinal studies with clear operational definitions and culturally sensitive measures. Collaboration across neuroscience, clinical trials, palliative care, and the humanities will be essential to clarify mechanisms and inform evidence-based practice. For stakeholders in psychedelic research and care, the key takeaway is that spiritual well-being is clinically relevant, but its neural and therapeutic foundations require much more rigorous investigation before definitive claims or policy shifts are warranted.

How we research: This article was written and reviewed by Dr. Alex M. Carter, PhD (Neuroscience, University of Toronto), with reference to the original review (OpenAlex W7215068344), FDA guidance on clinical trial endpoints, and recent clinical trial registries. Reviewed October 2026.